China overtakes America in research spending: the realignment of global scientific power

Chinese researchers and policymakers have long set their sights on scientific leadership. The milestone has now been reached. According to a March 2026 report from the Organisation for Economic Co-operation and Development, China’s investment in research and development, measured by purchasing power, has surpassed that of the United States. Both nations have crossed the US$1 trillion threshold, but the trajectory tells the deeper story: Chinese R&D spending has grown systematically over decades, while U.S. federal investment has declined from its 2010 peak.

This is not merely a symmetrical shift in expenditure. It represents a reordering of the global knowledge economy that carries direct implications for every industry reliant on cutting-edge discovery. Chinese entities already hold a commanding lead in patent filings, with roughly 1.8 million applications in 2024 versus just over 600,000 for the United States. China also overtook the U.S. in total scientific publications, high-impact papers, and entries in the highly selective Nature Index. The American advantage in highly cited research has evaporated.

For global professionals, the immediate takeaway is not about rankings. It is about capacity. A nation that reduces its investment in basic science simultaneously reduces its ability to absorb and apply the discoveries of others. The risk for the U.S. is not just falling behind in production, but falling behind in translation. China, by contrast, is building an integrated system: state-supported research universities, robust federal laboratories, and a commercial sector increasingly oriented toward open publication and international engagement. The result is an environment where foreign talent finds not only funding but opportunity.

Why it matters:
For multinational corporations and research-intensive enterprises, the center of gravity for innovation is shifting. Supply chain decisions, patent strategy, and the sourcing of scientific expertise increasingly require serious attention to Chinese institutions. The U.S. research ecosystem is under political and budgetary pressure, while China is actively expanding its capacity. Companies that fail to engage with Chinese science risk losing access to the next generation of foundational discoveries.

Source →